A Study Comparing the Efficacy and Safety of G-CHOP Versus R-CHOP in Untreated Diffuse Large B-cell Lymphoma Patients

NCT03650933 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

360

Enrollment

INDUSTRY

Sponsor class

Conditions

Diffuse Large B-Cell Lymphoma, Unspecified Site

Interventions

BIOLOGICAL: G-CHOP
BIOLOGICAL: R-CHOP

Sponsor

Nanjing Yoko Biomedical Co., Ltd.